These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6140137)

  • 1. Stereochemical composition of propranolol metabolites in the dog using stable isotope-labeled pseudoracemates.
    Walle T; Wilson MJ; Walle UK; Bai SA
    Drug Metab Dispos; 1983; 11(6):544-9. PubMed ID: 6140137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereoselective increase in propranolol bioavailability during chronic dosing in the dog.
    Bai SA; Wilson MJ; Walle UK; Walle T
    J Pharmacol Exp Ther; 1983 Nov; 227(2):360-4. PubMed ID: 6631718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereoselective ring oxidation of propranolol in man.
    Walle T; Walle UK; Wilson MJ; Fagan TC; Gaffney TE
    Br J Clin Pharmacol; 1984 Nov; 18(5):741-8. PubMed ID: 6508983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative account of propranolol metabolism in urine of normal man.
    Walle T; Walle UK; Olanoff LS
    Drug Metab Dispos; 1985; 13(2):204-9. PubMed ID: 2859169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereoselective oral bioavailability of (+/-)-propranolol in the dog. A GC-MS study using a stable isotope technique.
    Walle T; Walle UK
    Res Commun Chem Pathol Pharmacol; 1979 Mar; 23(3):453-64. PubMed ID: 461970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of diltiazem on the disposition and metabolism of the enantiomers of propranolol in the dog during multiple oral dosing.
    Lankford SM; Maskasame C; Bai SA
    Drug Metab Dispos; 1994; 22(5):776-87. PubMed ID: 7835231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-dealkylation of propranolol in rat, dog, and man. Chemical and stereochemical aspects.
    Nelson WL; Bartels MJ
    Drug Metab Dispos; 1984; 12(3):345-52. PubMed ID: 6145562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative metabolic fate of propranolol in the dog, rat, and hamster using radiotracer, high performance liquid chromatography, and gas chromatography-mass spectrometry techniques.
    Bargar EM; Walle UK; Bai SA; Walle T
    Drug Metab Dispos; 1983; 11(3):266-72. PubMed ID: 6135586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and metabolism of a 4'-methylthio derivative of propranolol in the dog.
    Bai SA; Easterling DE; Wilson MJ; Walle UK; Haney CA; Peet NP; Pruett JK; Walle T
    Drug Metab Dispos; 1989; 17(5):495-505. PubMed ID: 2573492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereochemistry of the in vivo disposition and metabolism of propranolol in dog and man using deuterium-labeled pseudoracemates.
    Walle T
    Drug Metab Dispos; 1985; 13(3):279-82. PubMed ID: 2861983
    [No Abstract]   [Full Text] [Related]  

  • 11. New ring-hydroxylated metabolites of propranolol: species differences and stereospecific 7-hydroxylation.
    Walle T; Oatis JE; Walle UK; Knapp DR
    Drug Metab Dispos; 1982; 10(2):122-7. PubMed ID: 6124396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and metabolism of the pharmacologically active 4'-hydroxylated metabolite of propranolol in the dog.
    Christ DD; Walle UK; Oatis JE; Walle T
    Drug Metab Dispos; 1990; 18(1):1-4. PubMed ID: 1970766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of major sulfate conjugates in the metabolism of propranolol in dog and man.
    Walle T; Walle UK; Knapp DR; Conradi EC; Bargar EM
    Drug Metab Dispos; 1983; 11(4):344-9. PubMed ID: 6137341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the metabolic pathways of alprenolol in man and the dog using stable isotopes.
    Hoffmann KJ; Arfwidsson A; Borg KO; Skånberg I
    Biomed Mass Spectrom; 1978 Nov; 5(11):634-40. PubMed ID: 749958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and metabolism of oral doses of a 4'-methylthio derivative of propranolol in man.
    Walle T; Walle UK; Cowart TD; Conradi EC; Gaffney TE
    Xenobiotica; 1990 Mar; 20(3):321-31. PubMed ID: 2336841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New metabolites of di(2-ethylhexyl)phthalate (DEHP) in human urine and serum after single oral doses of deuterium-labelled DEHP.
    Koch HM; Bolt HM; Preuss R; Angerer J
    Arch Toxicol; 2005 Jul; 79(7):367-76. PubMed ID: 15700144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidation of (R)- and (S)-propranolol in human and dog liver microsomes. Species differences in stereoselectivity.
    von Bahr C; Hermansson J; Lind M
    J Pharmacol Exp Ther; 1982 Aug; 222(2):458-62. PubMed ID: 7097564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites.
    Prakash C; Cui D
    Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS.
    Prakash C; Soliman V
    Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enantioselective biotransformation of the chiral antihistaminic drug dimethindene in humans and rats.
    Prien D; Rehn D; Blaschke G
    Arzneimittelforschung; 1997 May; 47(5):653-8. PubMed ID: 9205781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.